ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 97 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2018. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $154,000 | -16.3% | 29,053 | -8.4% | 0.01% | -21.4% |
Q1 2018 | $184,000 | +70.4% | 31,732 | -15.5% | 0.01% | +100.0% |
Q4 2016 | $108,000 | -73.3% | 37,555 | -61.8% | 0.01% | -75.9% |
Q3 2016 | $404,000 | -12.7% | 98,382 | -32.9% | 0.03% | -9.4% |
Q2 2016 | $463,000 | – | 146,520 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 919,000 | $4,816,000 | 2.29% |
RTW INVESTMENTS, LP | 6,256,840 | $32,786,000 | 2.24% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $2,515,000 | 1.08% |
Bpifrance SA | 828,262 | $4,340,000 | 0.49% |
WS MANAGEMENT LLLP | 888,722 | $4,657,000 | 0.28% |
Eventide Asset Management | 1,146,580 | $6,008,000 | 0.21% |
683 Capital Management, LLC | 362,386 | $1,899,000 | 0.17% |
Orbimed Advisors | 1,243,200 | $6,514,000 | 0.10% |
Sofinnova Investments, Inc. | 159,237 | $835,000 | 0.08% |
Rhenman & Partners Asset Management AB | 119,673 | $627,000 | 0.07% |